BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2024 6:00:27 AM | Browse: 396 | Download: 1028
Publication Name World Journal of Clinical Cases
Manuscript ID 101306
Country Malaysia
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Editorial
Article Title Revolutionizing diabetic retinopathy screening and management: The role of artificial intelligence and machine learning
Manuscript Source Invited Manuscript
All Author List Mona Mohamed Ibrahim Abdalla and Jaiprakash Mohanraj
ORCID
Author(s) ORCID Number
Mona Mohamed Ibrahim Abdalla http://orcid.org/0000-0002-4987-9517
Funding Agency and Grant Number
Corresponding Author Mona Mohamed Ibrahim Abdalla, MD, PhD, Department of Human Biology, School of Medicine, International Medical University, No. 126 Jln Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia. monamohamed@imu.edu.my
Key Words Diabetic retinopathy; Artificial intelligence; Machine learning; Screening; Management; Predictive analytics; Personalized medicine
Core Tip Leveraging artificial intelligence (AI) and machine learning in diabetic retinopathy care can significantly enhance early detection and personalized treatment. Clinicians should embrace AI-driven screening tools that analyze retinal images with high precision, reducing the risk of human error and improving diagnostic accuracy. Implementing predictive analytics can help in identifying patients at higher risk, allowing for timely interventions and tailored treatment plans. To maximize the benefits, healthcare systems must invest in training and integrating these technologies seamlessly into clinical workflows. Collaborations between technologists and healthcare providers are crucial for developing robust, ethical, and equitable AI solutions in ophthalmic care.
Publish Date 2024-11-19 06:00
Citation

Abdalla MMI, Mohanraj J. Revolutionizing diabetic retinopathy screening and management: The role of artificial intelligence and machine learning. World J Clin Cases 2025; 13(5): 101306

URL https://www.wjgnet.com/2307-8960/full/v13/i5/101306.htm
DOI https://dx.doi.org/10.12998/wjcc.v13.i5.101306
Full Article (PDF) WJCC-13-101306-with-cover.pdf